These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15567463)

  • 1. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
    Kirszberg C; Rumjanek VM; Monteiro RQ
    Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL induces components of the extrinsic coagulation pathway in osteoclasts.
    Karlström E; Ek-Rylander B; Wendel M; Andersson G
    Biochem Biophys Res Commun; 2010 Apr; 394(3):593-9. PubMed ID: 20214889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
    Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
    Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual modulation of prothrombin activation by the cyclopentapeptide plactin.
    Harada T; Tsuruta T; Yamagata K; Inoue T; Hasumi K
    FEBS J; 2009 May; 276(9):2516-28. PubMed ID: 19476492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and assembly of procoagulant complexes by human pleural mesothelial cells.
    Kumar A; Koenig KB; Johnson AR; Idell S
    Thromb Haemost; 1994 May; 71(5):587-92. PubMed ID: 8091385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
    Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
    Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.
    Majumder R; Weinreb G; Lentz BR
    Biochemistry; 2005 Dec; 44(51):16998-7006. PubMed ID: 16363813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
    Stevic I; Berry LR; Chan AK
    J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin and its derivatives stimulate motility of melanoma cells.
    Zhou H; Gabazza EC; Takeya H; Deguchi H; Urano H; Adachi Y; Suzuki K
    Thromb Haemost; 1998 Sep; 80(3):407-12. PubMed ID: 9759619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor X-dependent, thrombin-generating activities on a neuroblastoma cell and their disappearance upon differentiation.
    Inuyama H; Saito T; Takagi J; Saito Y
    J Cell Physiol; 1997 Dec; 173(3):406-14. PubMed ID: 9369954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assembly of the prothrombinase complex on adherent platelets.
    Swords NA; Mann KG
    Arterioscler Thromb; 1993 Nov; 13(11):1602-12. PubMed ID: 8218101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
    Rezaie AR
    Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.